Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30560927.
- Also identified by DOI 10.1038/s41467-018-07806-6 and PMC identifier 6299086.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Foxp3<sup>+</sup>CD4<sup>+</sup> regulatory T (T<sub>reg</sub>) cells are essential for preventing fatal autoimmunity and safeguard immune homeostasis in vivo. While expression of the transcription factor Foxp3 and IL-2 signals are both required for the development and function of T<sub>reg</sub> cells, the commitment to the T<sub>reg</sub> cell lineage occurs during thymic selection upon T cell receptor (TCR) triggering, and precedes the expression of Foxp3. Whether signals beside TCR contribute to establish T<sub>reg</sub> cell epigenetic and functional identity is still unknown. Here, using a mouse model with reduced IL-2 signaling, we show that IL-2 regulates the positioning of the pioneer factor SATB1 in CD4<sup>+</sup> thymocytes and controls genome wide chromatin accessibility of thymic-derived T<sub>reg</sub> cells. We also show that T<sub>reg</sub> cells receiving only low IL-2 signals can suppress endogenous but not WT autoreactive T cell responses in vitro and in vivo. Our findings have broad implications for potential therapeutic strategies to reprogram T<sub>reg</sub> cells in vivo.
Medical subject headings
- Cellular Reprogramming
- Epigenesis, Genetic
- Interleukin-2
- Matrix Attachment Region Binding Proteins
- T-Lymphocytes, Regulatory